June 9, 2017
EU regulators who want to encourage understanding and acceptance of biosimilar medicines might consider improving the drugs’ labels.
June 6, 2017
For chronic migraine patients, the only thing better than making a headache stop is preventing it altogether. And new research suggests that patients may soon have new options for doing just that.
June 2, 2017
Abuse-deterrent formulations (ADF) of opioids resist crushing or dissolving for misuse, helping to curb widespread opioid abuse.
But a recent report from the Institute for Clinical and Economic Review underestimates ADFs’ value by ignoring several key benefits.
June 2, 2017
ICER’s report on opioid ADFs lays out several important facts. First, pain is a significant medical problem with potentially devastating…
June 1, 2017
A congressional effort to improve patients’ access to treatment is generating widespread enthusiasm in the advocacy community.
May 30, 2017
Orphan drugs aren’t always reaching the patients who need them, and an advocacy group known as the Cystic Fibrosis Engagement Network has a few ideas as to why.
May 25, 2017
Is precision medicine gaining traction in the field of oncology? The Food and Drug Administration’s recent approval of the cancer drug pembrolizumab offers a hint.
May 23, 2017
Some Medicare beneficiaries pay 20 percent of their income in out-of-pocket medical expenses, a new study finds.
May 18, 2017
Long considered an affliction of the baby boomer generation, hepatitis C now has spiked among a surprising new population: young people.
May 16, 2017
One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals. And that statistic begs a crucial question: How can we really ensure patients’ safety in an age of sophisticated medications and accelerated approval processes?
